Venus Continues To Drive TAVR In China By Licensing In Australian Start-Up Tech

 
• By Barnaby Pickering

Venus Medtech has agreed a licensing deal with Endoluminal Sciences, an Australian start-up with technology to prevent paravalvular leakage and improve TAVR outcomes.

Transcatheter aortic valve replacement implantation TAVR TAVI minimally invasive surgery for treatment Aortic stenosis AS blocked

More from Deals

More from Business